Watermark

BG-C9074-101

Recruiting

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BG-C9074-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2023-509958-65-00

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents